Regulation of thymic regeneration by GPR39
GPR39 对胸腺再生的调节
基本信息
- 批准号:10502128
- 负责人:
- 金额:$ 62.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAgeAgingAgonistAllogenicApoptosisAutoimmune DiseasesBMP4Biological AvailabilityCell AgingCell CompartmentationCell DeathCell physiologyCellsChronicClinicalCommunicable DiseasesDataDevelopmentDietDietary SupplementationEndothelial CellsExhibitsExposure toG-Protein-Coupled ReceptorsGPR39 geneGenerationsGeneticHematopoieticHematopoietic Stem Cell TransplantationImmuneImmunocompetenceIndividualInfectionInjuryLeadLymphoid CellLymphopeniaMalignant - descriptorMalignant NeoplasmsMediatingMethodsModelingMolecularMorbidity - disease rateMusNatural regenerationNuclear AccidentsOutcomePathway interactionsPatientsPatternPersonsPopulation HeterogeneityProcessProductionProteinsPubertyRadiation InjuriesRadiation therapyRegenerative capacityRegenerative pathwayRegenerative responseRegulationRoleShockSignal TransductionSiteStressStromal CellsT cell reconstitutionT-Cell DevelopmentT-LymphocyteTerrorismTestingTherapeuticThymic epithelial cellThymus GlandTransition ElementsTransplantationZincZinc supplementationage relatedagedbasecancer therapychemotherapyconditioningdrinking waterepithelial repairextracellularfunctional declinegraft vs host diseasehematopoietic cell transplantationimmunogenic cell deathimprovedinnovationinterleukin-22mortalitypreclinical studyregenerativerepairedresponserestorationsevere injurysmall moleculethymic regenerationthymocytetissue regeneration
项目摘要
PROJECT SUMMARY
The thymus, which is the primary site of T cell generation, is extremely sensitive to injury; but also has
a remarkable capacity for endogenous repair. However, even though there is continual thymic involution and
regeneration in response to everyday insults like stress and infection, profound thymic damage caused by
common cancer therapies and the conditioning regimes for hematopoietic cell transplantation (HSCT) lead to
prolonged T cell lymphopenia. Furthermore, in the context of allogeneic HCT, the thymus is an extremely
sensitive target to alloreactive T cells during graft versus host disease (GVHD). Consequently, identification of
therapies that can boost T cell reconstitution in recipients of HSCT is a clinical priority.
We have previously identified two distinct pathways of endogenous thymic regeneration, centered on
the production of the regeneration factors IL-22 by innate lymphoid cells (ILCs), and BMP4 by endothelial cells
(ECs); both of which mediate their regenerative effects by targeting thymic epithelial cells (TECs). In our
preliminary data we have shown that Zinc (Zn), which is the second most abundant transition metal in the
body, is critically important for T cell development; with mice fed a Zn-deficient diet exhibiting a profound block
in the differentiation and expansion of thymocytes, which was reversed with dietary supplementation of Zn in
drinking water. Although Zn, which is a co-factor for over 300 proteins and has been implicated in cell
processes such as proliferation and apoptosis, directly influences T cell development at the level of
thymocytes, we found an increase in the levels of extracellular Zn after damage; and that this translocation of
Zn could directly stimulate the damage-associated production of BMP4 by ECs via sensing of Zn by the G-
protein-coupled receptor GPR39.m These studies suggest that under steady-state conditions Zn is used to
promote T cell development, but after damage, Zn released by thymocytes is capable of triggering the
regenerative response by ECs by stimulating GPR39, effectively acting as a damage-associated molecular
pattern (DAMP). Based on our preliminary data, we hypothesize that (a) a switch toward immunogenic cell
death (ICD) in thymocytes after damage leads to the extracellular release of Zn; (b) GPR39-sensing of
released zinc is a master regulator of the endogenous regenerative response to acute damage; and (c)
activation of GPR39 signaling can be exploited into a superior method to promote thymic function and T cell
reconstitution following HSCT. Specifically, our proposal has the following aims: (1) to investigate the ability of
GPR39 signaling to induce multiple distinct pathways of endogenous regeneration after damage; (2) to identify
the role of thymocyte cell death in initiating the production of regenerative factors; and (3) to evaluate if
modulation of GPR39 signaling can be used as a means of improving T cell reconstitution following HSCT.
The studies outlined in this proposal not only have the potential to define important pathways
underlying tissue regeneration but could also result in innovative clinical approaches to enhance thymic
function.
项目摘要
胸腺是T细胞生成的主要部位,对损伤极其敏感;但也具有
一种非凡的内源性修复能力然而,即使有持续的胸腺退化,
再生反应日常侮辱,如压力和感染,深刻的胸腺损伤所造成的
常见的癌症治疗和造血细胞移植(HSCT)的调节方案导致
长期T细胞淋巴细胞减少症此外,在同种异体HCT的情况下,胸腺是一个非常重要的器官。
在移植物抗宿主病(GVHD)期间,对同种异体反应性T细胞敏感的靶点。因此,
可以促进HSCT接受者中T细胞重建的疗法是临床优先考虑的。
我们以前已经确定了两种不同的内源性胸腺再生途径,
先天性淋巴样细胞(ILC)产生再生因子IL-22,内皮细胞产生BMP 4
(ECs)两者都通过靶向胸腺上皮细胞(TEC)介导其再生作用。在我们
我们的初步数据表明,锌(Zn),这是第二个最丰富的过渡金属在
身体,是至关重要的T细胞的发展;与小鼠喂养锌缺乏饮食表现出深刻的阻滞
在胸腺细胞的分化和扩张,这是逆转与饲料中补充锌,
饮用水虽然锌是300多种蛋白质的辅因子,并与细胞凋亡有关,
过程,如增殖和凋亡,直接影响T细胞的发展水平,
胸腺细胞,我们发现细胞外锌水平的增加后,损害;和这种易位,
锌可通过G-受体感受锌直接刺激内皮细胞产生损伤相关的BMP-4。
蛋白偶联受体GPR 39。这些研究表明,在稳态条件下,
促进T细胞发育,但在损伤后,胸腺细胞释放的锌能够触发T细胞的发育。
通过刺激GPR 39,有效地作为损伤相关分子,
模式(DAMP)。基于我们的初步数据,我们假设(a)向免疫原性细胞的转变,
(B)受损后胸腺细胞中的死亡(ICD)导致Zn的细胞外释放;
释放的锌是对急性损伤的内源性再生反应的主要调节剂;和(c)
GPR 39信号传导的激活可被开发成促进胸腺功能和T细胞增殖的上级方法。
HSCT后重建。具体而言,我们的建议有以下目的:(1)调查的能力,
GPR 39信号传导诱导损伤后内源性再生的多种不同途径;(2)鉴定
胸腺细胞死亡在启动再生因子产生中的作用;以及(3)评估是否
GPR 39信号传导的调节可用作改善HSCT后T细胞重建的手段。
该提案中概述的研究不仅有可能确定重要的途径,
潜在的组织再生,但也可能导致创新的临床方法,以提高胸腺
功能
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrod Dudakov其他文献
Jarrod Dudakov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrod Dudakov', 18)}}的其他基金
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction
调节损伤相关分子模式的信号传导以改善辐射引起的胸腺功能障碍
- 批准号:
10667548 - 财政年份:2022
- 资助金额:
$ 62.32万 - 项目类别:
Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction
调节损伤相关分子模式的信号传导以改善辐射引起的胸腺功能障碍
- 批准号:
10474884 - 财政年份:2022
- 资助金额:
$ 62.32万 - 项目类别:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
利用胸腺再生的内源机制增强造血细胞移植受者的免疫功能
- 批准号:
10656565 - 财政年份:2019
- 资助金额:
$ 62.32万 - 项目类别:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
利用胸腺再生的内源机制增强造血细胞移植受者的免疫功能
- 批准号:
10545013 - 财政年份:2019
- 资助金额:
$ 62.32万 - 项目类别:
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
利用胸腺再生的内源机制增强造血细胞移植受者的免疫功能
- 批准号:
10322998 - 财政年份:2019
- 资助金额:
$ 62.32万 - 项目类别:
Response of aged thymus to injury and rejuvenation signals
衰老胸腺对损伤和恢复活力信号的反应
- 批准号:
10553993 - 财政年份:2017
- 资助金额:
$ 62.32万 - 项目类别:
Investigating the role of interleukin-22 in thymus function
研究 IL-22 在胸腺功能中的作用
- 批准号:
9189154 - 财政年份:2016
- 资助金额:
$ 62.32万 - 项目类别:
Investigating the role of interleukin-22 in thymus function
研究 IL-22 在胸腺功能中的作用
- 批准号:
9268742 - 财政年份:2016
- 资助金额:
$ 62.32万 - 项目类别:
Investigating the role of interleukin-22 in thymus function
研究 IL-22 在胸腺功能中的作用
- 批准号:
8488026 - 财政年份:2013
- 资助金额:
$ 62.32万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 62.32万 - 项目类别:
Operating Grants














{{item.name}}会员




